SARTORIUS (UNSP.ADS)/1/5 (SRT0) - Cash Flow Conversion Efficiency
Based on the latest financial reports, SARTORIUS (UNSP.ADS)/1/5 (SRT0) has a cash flow conversion efficiency ratio of 0.049x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€188.90 Million ≈ $220.84 Million USD) by net assets (€3.89 Billion ≈ $4.55 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is SARTORIUS (UNSP.ADS)/1/5's balance sheet to measure how much of total assets are equity-financed.
SARTORIUS (UNSP.ADS)/1/5 - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how SARTORIUS (UNSP.ADS)/1/5's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check SRT0 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
SARTORIUS (UNSP.ADS)/1/5 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SARTORIUS (UNSP.ADS)/1/5 ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Central Pattana Public Company Limited
BK:CPN
|
0.078x |
|
Central Pattana Public Company Limited
BK:CPN-R
|
0.078x |
|
Korea Aerospace Industries
KO:047810
|
-0.073x |
|
WISETECH GLOBAL USP.ADRS
F:17W0
|
N/A |
|
ISUZU MOTORS LTD ADR
F:ISUA
|
N/A |
|
Pilbara Minerals Ltd
AU:PLS
|
0.044x |
|
Watts Water Technologies Inc
NYSE:WTS
|
0.009x |
|
Empresas Copec S.A.
SN:COPEC
|
0.017x |
Annual Cash Flow Conversion Efficiency for SARTORIUS (UNSP.ADS)/1/5 (2022–2025)
The table below shows the annual cash flow conversion efficiency of SARTORIUS (UNSP.ADS)/1/5 from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see SRT0 market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €3.87 Billion ≈ $4.52 Billion |
€837.00 Million ≈ $978.54 Million |
0.216x | -13.58% |
| 2024-12-31 | €3.90 Billion ≈ $4.56 Billion |
€976.20 Million ≈ $1.14 Billion |
0.250x | -19.08% |
| 2023-12-31 | €2.76 Billion ≈ $3.22 Billion |
€853.60 Million ≈ $997.95 Million |
0.309x | +12.09% |
| 2022-12-31 | €2.66 Billion ≈ $3.11 Billion |
€734.20 Million ≈ $858.36 Million |
0.276x | -- |
About SARTORIUS (UNSP.ADS)/1/5
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell cult… Read more